유럽의 내피기능장애 시장 예측 - 지역별 분석 : 원인별, 검사 유형별, 최종 사용자별(-2028년)

Europe Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause, Test Type, and End User

US $ 3,450 ￦ 4,749,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.

US $ 4,450 ￦ 6,126,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,450 ￦ 7,503,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

유럽의 내피기능장애 시장은 2022년 6억 1,128만 달러로 평가되었고, 2028년 7억 7,637만 달러로 성장할 것으로 예측됩니다. 2022년부터 2028년까지 CAGR은 4.1%로 추정됩니다.

높은 콜레스테롤, 당뇨병, 비만 증가가 유럽의 내피기능장애 시장을 뒷받침

라이프 스타일의 변화로 당뇨병, 고혈압, 지질 이상증, 비만의 이환율이 상승하여 내피기능장애의 가능성이 높아지고 있습니다. 그러나 이들은 적극적인 모니터링, 조기 진단, 신체 활동으로 예방할 수 있습니다. 대사 증후군은 CAD, 당뇨병, 고혈압 및 기타 심각한 건강 문제의 위험을 증가시키는 질병 그룹입니다. 2형 당뇨병은 이미 공중보건에 큰 문제가 되고 있으며, 비만과 관련된 어린이와 젊은 성인들 사이에서 점점 증가하고 있습니다. 세계보건기구(WHO)에 따르면 2019년에는 당뇨병이 150만 명의 사망의 직접적인 원인이 되었고, 당뇨병에 의한 사망의 48%는 70세까지 일어나고 있습니다. 또한 신장병에 의한 46만명의 사망도 당뇨병이 원인이었습니다. 혈당치의 상승은 심혈관계 사망의 20%까지 일으킵니다.

고혈압은 세계의 심혈관 질환 및 조사의 주요 원인입니다. 임페리얼 칼리지 런던과 WHO가 주도한, 인구에서의 고혈압 유병률, 발견, 치료, 컨트롤의 동향에 관한 최초의 종합적인 세계적 분석에 의하면, 30-79세의 성인 고혈압 환자수는 지난 30년간 6억 5,000만 명에서 12억 8,000만 명으로 증가하고 있습니다.

유럽의 내피기능장애 시장 개요

유럽의 내피기능장애 시장은 영국, 독일, 이탈리아, 프랑스, 스페인 및 기타 유럽으로 세분화됩니다. 심혈관 질환의 유병률 상승, 고령화 인구 증가, 연구개발 활동의 활성화가 이 지역 시장 성장에 기여하는 주요 요인입니다. 또한 제품 출시 및 정부 투자는 예측 기간 동안 시장 성장을 가속할 것으로 보입니다.

유럽의 내피기능장애 시장 수익 및 예측(금액)(-2028년)

유럽 내피기능장애 시장의 세분화

유럽의 내피기능장애 시장은 원인별, 검사 유형별, 최종 사용자별 및 국가별로 세분화됩니다.

원인별로, 유럽의 내피기능장애 시장은 고혈압, 고콜레스테롤 혈증, 비만, 당뇨병, 베체트병 등으로 구분됩니다. 2022년 유럽의 내피기능장애 시장 점유율은 고혈압 부문이 최대를 기록했습니다.

검사 유형에 따라 유럽의 내피기능장애 시장은 침습적 검사 및 비침습적 검사로 구분됩니다. 침습적 검사 부문은 2022년 유럽의 내피기능장애 시장 점유율에서 더 큰 비율을 차지했습니다. 비침습적 검사 부문은 또한 혈류 의존성 혈관 확장 반응, 말초 동맥 토노메트리(PAT), 정맥 폐색 플레티스모그래피, 순환 마커 등으로 세분화됩니다.

최종 사용자를 기반으로 유럽의 내피기능장애 시장은 병원, 진단센터, 클리닉 등으로 분류됩니다. 병원 부문은 2022년 유럽의 내피기능장애 시장에서 가장 큰 점유율을 차지했습니다.

국가별로 유럽의 내피기능장애 시장은 영국, 독일, 이탈리아, 프랑스, 스페인 및 기타 유럽으로 구분됩니다. 2022년 유럽의 내피기능장애 시장은 독일이 독점했습니다.

ZOLL Medical Corp, Spingo Tec GmbH, The Polymath Co, SMART Medical Ltd, Alam Medical SaRl, Medizinische Messtechnik GmbH는 이 지역의 내피기능장애 시장에서 사업을 전개하고 있는 주요 기업의 일부입니다.

목차

제1장 서론

제2장 유럽의 내피기능장애 시장-요점

제3장 조사 방법

• 조사 범위
• 2차 조사
• 1차 조사

제4장 유럽의 내피기능장애 시장-시장 정세

• 개관
• PEST 분석
  • 유럽의 PEST 분석
• 전문가의 견해

제5장 유럽 내피기능장애 시장 : 주요시장 역학

• 시장 성장 촉진요인
  • 심혈관 질환 증가
  • 고콜레스테롤, 당뇨병, 비만 증가
• 시장 성장 억제요인
  • 내피기능장애의 스크리닝 기술에 수반하는 단점
• 시장 기회
  • 신규 바이오마커 및 치료 전략의 이용 증가
• 향후 동향
  • 내피기능장애를 평가하기 위한 비침습적 방법의 사용
• 영향 분석

제6장 내피기능장애 시장 : 유럽 분석

• 유럽 내피기능장애 시장의 수익 예측 및 분석

제7장 유럽의 내피기능장애 시장 분석 : 원인별

• 유럽의 내피기능장애 시장 : 원인별(%)(2022년, 2028년)
• 고혈압
• 당뇨병
• 고콜레스테롤 혈증
• 베체트병
• 비만증
• 기타

제8장 유럽의 내피기능장애 시장 분석 : 검사 유형별

• 유럽의 내피기능장애 시장 : 검사 유형별(%)(2022년, 2028년)
• 침습적 검사
• 비침습적 검사

제9장 유럽의 내피기능장애 시장 분석 : 최종 사용자별

• 유럽의 내피기능장애 시장 : 최종사용자별(%)(2022년, 2028년)
• 병원
• 진단센터
• 클리닉
• 기타

제10장 유럽의 내피기능장애 시장-수익 및 예측 : 국가별 분석(-2028년)

• 유럽

제11장 유럽의 내피기능장애 시장-업계 정세

• 내피기능장애 시장에서의 성장전략
• 무기적 성장 전략
• 유기적 성장 전략

제12장 기업 프로파일

• ZOLL Medical Corp
• Sphingo Tec GmbH
• The Polymath Co
• SMART Medical Ltd
• Alam Medical SaRl
• Medizinische Messtechnik GmbH

제13장 부록

AJY

영문 목차

영문목차

The Europe endothelial dysfunction market is expected to grow from US$ 611.28 million in 2022 to US$ 776.37 million by 2028. It is estimated to grow at a CAGR of 4.1% from 2022 to 2028.

Rising Incidences of High Cholesterol, Diabetes and Obesity Fuels Europe Endothelial Dysfunction Market

Lifestyle changes lead to a rise in the incidences of diabetes, hypertension, dyslipidemia, and obesity, increasing the chances of endothelial dysfunction. However, these can be prevented through proactive monitoring, early diagnosis, and physical activity. Metabolic syndrome is a group of disorders that increases the risk of CAD, diabetes, high blood pressure, and other serious health problems. Type 2 diabetes is already a major public health problem and is increasingly rising among the children and young adults associated with obesity. According to the World Health Organization (WHO), diabetes was the direct cause of 1.5 million deaths in 2019, and 48% of all deaths from diabetes occurred before age 70. Another 460,000 deaths from kidney disease were caused by diabetes. Elevated blood sugar causes ~20% of cardiovascular deaths.

Hypertension is the leading cause of cardiovascular disease and premature death worldwide. The number of adults aged 30-79 with hypertension has increased from 650 million to 1.28 billion over the past 30 years, according to the first comprehensive global analysis of trends in the prevalence, detection, treatment, and control of hypertension among the population, headed by Imperial College London and WHO.

Europe Endothelial Dysfunction Market Overview

The endothelial dysfunction market in Europe is sub-segmented into the UK, Germany, Italy, France, Spain, and the Rest of Europe. The rising prevalence of cardiovascular diseases, an increase in the aging population, and a growing number of research and development activities are the key factors contributing to the market growth in the region. Further, product launches and government investments would facilitate the market growth during the forecast period.

Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Europe Endothelial Dysfunction Market Segmentation

The Europe endothelial dysfunction market is segmented into cause, test type, end user, and country.

Based on cause, the Europe endothelial dysfunction market is segmented into hypertension, hypercholesterolaemia, obesity, diabetes, behcet's disease, and others. The hypertension segment registered the largest Europe endothelial dysfunction market share in 2022.

Based on test type, the Europe endothelial dysfunction market is segmented into invasive test and non-invasive test. The invasive test segment held a larger Europe endothelial dysfunction market share in 2022. The non-invasive test segment is further subsegmented into flow mediated dilatory, peripheral arterial tonometry (PAT), venous occlusion pletismography, circulating markers, and others.

Based on end user, the Europe endothelial dysfunction market has been categorized into hospitals, diagnostic centers, clinics, and others. The hospitals segment held the largest Europe endothelial dysfunction market share in 2022.

Based on country, the Europe endothelial dysfunction market is segmented into the UK, Germany, Italy, France, Spain, and the Rest of Europe. Germany dominated the Europe endothelial dysfunction market in 2022.

ZOLL Medical Corp, Sphingo Tec GmbH, The Polymath Co, SMART Medical Ltd, Alam Medical SaRl, and Medizinische Messtechnik GmbH are some of the leading companies operating in the endothelial dysfunction market in the region.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe endothelial dysfunction market.
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Europe endothelial dysfunction market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the endothelial dysfunction market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

• 1.1 Scope of the Study
• 1.2 The Insight Partners Research Report Guidance
• 1.3 Market Segmentation
  • 1.3.1 Europe Endothelial Dysfunction Market - by Cause
  • 1.3.2 Europe Endothelial Dysfunction Market - by Test Type
  • 1.3.3 Europe Endothelial Dysfunction Market - by End User
  • 1.3.4 Europe Endothelial Dysfunction Market - by Country

2. Europe Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Europe Endothelial Dysfunction Market - Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis
  • 4.2.1 Europe PEST Analysis
• 4.3 Expert Opinion

5. Europe Endothelial Dysfunction Market - Key Market Dynamics

• 5.1 Market Drivers
  • 5.1.1 Increasing Incidences of Cardiovascular Diseases
  • 5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
• 5.2 Market Restraints
  • 5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
• 5.3 Market Opportunities
  • 5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
• 5.4 Future Trends
  • 5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
• 5.5 Impact Analysis

6. Endothelial Dysfunction Market - Europe Analysis

• 6.1 Europe Endothelial Dysfunction Market Revenue Forecast and Analysis

7. Europe Endothelial Dysfunction Market Analysis - by Cause

• 7.1 Overview
• 7.2 Europe Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
• 7.3 Hypertension
  • 7.3.1 Overview
  • 7.3.2 Hypertension: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
• 7.4 Diabetes
  • 7.4.1 Overview
  • 7.4.2 Diabetes: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
• 7.5 Hypercholestrolaemia
  • 7.5.1 Overview
  • 7.5.2 Hypercholestrolaemia: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
• 7.6 Behcet's Disease
  • 7.6.1 Overview
  • 7.6.2 Behcet's Disease: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
• 7.7 Obesity
  • 7.7.1 Overview
  • 7.7.2 Obesity: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
• 7.8 Others
  • 7.8.1 Overview
  • 7.8.2 Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8. Europe Endothelial Dysfunction Market Analysis - by Test Type

• 8.1 Overview
• 8.2 Europe Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
• 8.3 Invasive Tests
  • 8.3.1 Overview
  • 8.3.2 Invasive Tests: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
• 8.4 Non-Invasive Tests
  • 8.4.1 Overview
  • 8.4.2 Non-Invasive Tests: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4.3 Flow Mediated Dilatory
    • 8.4.3.1 Overview
    • 8.4.3.2 Flow Mediated Dilatory: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4.4 Venous Occlusion Plethysmography
    • 8.4.4.1 Overview
    • 8.4.4.2 Venous Occlusion Plethysmography: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4.5 Peripheral Arterial Tonometry (PAT)
    • 8.4.5.1 Overview
    • 8.4.5.2 Peripheral Arterial Tonometry (PAT): Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4.6 Circulating Markers
    • 8.4.6.1 Overview
    • 8.4.6.2 Circulating Markers: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4.7 Others
    • 8.4.7.1 Overview
    • 8.4.7.2 Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9. Europe Endothelial Dysfunction Market Analysis - by End User

• 9.1 Overview
• 9.2 Europe Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
• 9.3 Hospitals
  • 9.3.1 Overview
  • 9.3.2 Hospitals: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
• 9.4 Diagnostics Centers
  • 9.4.1 Overview
  • 9.4.2 Diagnostics Centers: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
• 9.5 Clinics
  • 9.5.1 Overview
  • 9.5.2 Clinics: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
• 9.6 Others
  • 9.6.1 Overview
  • 9.6.2 Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Country Analysis

• 10.1 Europe: Endothelial Dysfunction Market
  • 10.1.1 Overview
    • 10.1.1.1 Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.1.1 Overview
      • 10.1.1.1.2 Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.1.3 Germany: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
      • 10.1.1.1.4 Germany: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
      • 10.1.1.1.4.1 Germany: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.1.1.5 Germany: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
    • 10.1.1.2 UK: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.2.1 Overview
      • 10.1.1.2.2 UK: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.2.3 UK: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
      • 10.1.1.2.4 UK: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
      • 10.1.1.2.4.1 UK: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.1.2.5 UK: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
    • 10.1.1.3 France: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.3.1 Overview
      • 10.1.1.3.2 France: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.3.3 France: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
      • 10.1.1.3.4 France: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
      • 10.1.1.3.4.1 France: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.1.3.5 France: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
    • 10.1.1.4 Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.4.1 Overview
      • 10.1.1.4.2 Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.4.3 Italy: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
      • 10.1.1.4.4 Italy: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
      • 10.1.1.4.4.1 Italy: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.1.4.5 Italy: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
    • 10.1.1.5 Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.5.1 Overview
      • 10.1.1.5.2 Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.5.3 Spain: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
      • 10.1.1.5.4 Spain: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
      • 10.1.1.5.4.1 Spain: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.1.5.5 Spain: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
    • 10.1.1.6 Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.6.1 Overview
      • 10.1.1.6.2 Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.6.3 Rest of Europe: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
      • 10.1.1.6.4 Rest of Europe: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
      • 10.1.1.6.4.1 Rest of Europe: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.1.6.5 Rest of Europe: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

11. Europe Endothelial Dysfunction Market-Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in the Endothelial Dysfunction Market
• 11.3 Inorganic Growth Strategies
  • 11.3.1 Overview
• 11.4 Organic Growth Strategies
  • 11.4.1 Overview

12. Company Profiles

• 12.1 ZOLL Medical Corp
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 Sphingo Tec GmbH
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 The Polymath Co
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 SMART Medical Ltd
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 Alam Medical SaRl
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 Medizinische Messtechnik GmbH
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments

13. Appendix

• 13.1 About The Insight Partners
• 13.2 Glossary of Terms

관련자료